Iovance Biotherapeutics, Inc. (IOVA)
4.04
-0.19
(-4.49%)
USD |
NASDAQ |
Jun 08, 14:32
Iovance Biotherapeutics Market Cap : 1.770B for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 121.34M |
| Neurocrine Biosciences, Inc. | 16.52B |
| Amgen, Inc. | 185.97B |
| BioCryst Pharmaceuticals, Inc. | 2.117B |
| Imunon, Inc. | 7.846M |
Market Cap Related Metrics
| PS Ratio | 5.391 |
| Price to Book Value | 2.452 |
| Price | 4.04 |
| Earnings Yield | -23.52% |